Literature DB >> 26781252

Hypertension and Stroke in Patients with Left Ventricular Assist Devices (LVADs).

Joshua Z Willey1, Amelia K Boehme2, Francesco Castagna3, Melana Yuzefpolskaya3, A Reshad Garan3, Veli Topkara3, Paolo C Colombo3.   

Abstract

Stroke is one of the most dreaded complications of left ventricular assist device therapy in patients with end-stage congestive heart failure. There is strong evidence linking anticoagulation and infection with ischemic and hemorrhagic strokes, though recent data has emerged regarding the importance of elevated blood pressure. In the recently completed Heartware Ventricular Assist Device studies, a mean arterial pressure greater than 90 mmHg was associated with greater stroke risk, particularly the hemorrhagic subtype. In this review, we discuss recent evidence regarding deleterious effects of uncontrolled hypertension in patients with left ventricular devices, and propose measurement and management strategies.

Entities:  

Keywords:  Hypertension; Left ventricular assist device; Stroke

Mesh：

Year:  2016        PMID： 26781252      PMCID： PMC5518745          DOI： 10.1007/s11906-015-0618-1

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  32 in total

1.  Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device.

Authors:  Tomoko S Kato; P Christian Schulze; Jonathan Yang; Ernest Chan; Khurram Shahzad; Hiroo Takayama; Nir Uriel; Ulrich Jorde; Maryjane Farr; Yoshifumi Naka; Donna Mancini
Journal:  J Heart Lung Transplant       Date:  2011-10-08       Impact factor: 10.247

Review 2.  Ischemic brain injury in cerebral amyloid angiopathy.

Authors:  Yael D Reijmer; Susanne J van Veluw; Steven M Greenberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

3.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo
Journal:  Stroke       Date:  2015-05-28       Impact factor: 7.914

Review 4.  Hypertension mechanisms causing stroke.

Authors:  B B Johansson
Journal:  Clin Exp Pharmacol Physiol       Date:  1999-07       Impact factor: 2.557

5.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

6.  Predictors of Thromboembolic Events in Patients with Ventricular Assist Device.

Authors:  Amelia K Boehme; Salpy V Pamboukian; James F George; Chrisly Dillon; Emily B Levitan; Russell Griffin; T Mark Beasley; Gerald McGwin; James K Kirklin; Nita A Limdi
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

7.  Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device.

Authors:  Gregg M Lanier; Khristine Orlanes; Yacki Hayashi; Jennifer Murphy; Margaret Flannery; Rosie Te-Frey; Nir Uriel; Melana Yuzefpolskaya; Donna M Mancini; Yoshifumi Naka; Hiroo Takayama; Ulrich P Jorde; Ryan T Demmer; Paolo C Colombo
Journal:  Circ Heart Fail       Date:  2013-06-27       Impact factor: 8.790

Review 8.  Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support.

Authors:  Lauren T Wasson; Melana Yuzefpolskaya; Michiyori Wakabayashi; Hiroo Takayama; Yoshifumi Naka; Nir Uriel; Ulrich P Jorde; Ryan T Demmer; Paolo C Colombo
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

9.  2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association.

Authors:  William J Powers; Colin P Derdeyn; José Biller; Christopher S Coffey; Brian L Hoh; Edward C Jauch; Karen C Johnston; S Claiborne Johnston; Alexander A Khalessi; Chelsea S Kidwell; James F Meschia; Bruce Ovbiagele; Dileep R Yavagal
Journal:  Stroke       Date:  2015-06-29       Impact factor: 10.170

10.  Identifying Target Risk Factors Using Population Attributable Risks of Ischemic Stroke by Age and Sex.

Authors:  Tai Hwan Park; Youngchai Ko; Soo Joo Lee; Kyung Bok Lee; Jun Lee; Moon-Ku Han; Jong-Moo Park; Yong-Jin Cho; Keun-Sik Hong; Dae-Hyun Kim; Jae-Kwan Cha; Mi-Sun Oh; Kyung-Ho Yu; Byung-Chul Lee; Byung-Woo Yoon; Ji Sung Lee; Juneyoung Lee; Hee-Joon Bae
Journal:  J Stroke       Date:  2015-09-30       Impact factor: 6.967
View more
  7 in total

1.  LVAD Outflow Graft Angle and Thrombosis Risk.

Authors:  Alberto Aliseda; Venkat Keshav Chivukula; Patrick Mcgah; Anthony R Prisco; Jennifer A Beckman; Guilherme J M Garcia; Nahush A Mokadam; Claudius Mahr
Journal:  ASAIO J       Date:  2017 Jan/Feb       Impact factor: 2.872

Review 2.  The Unique Blood Pressures and Pulsatility of LVAD Patients: Current Challenges and Future Opportunities.

Authors:  Francesco Castagna; Eric J Stöhr; Alberto Pinsino; John R Cockcroft; Joshua Willey; A Reshad Garan; Veli K Topkara; Paolo C Colombo; Melana Yuzefpolskaya; Barry J McDonnell
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

3.  Regular consumption of green tea improves pulse pressure and induces regression of left ventricular hypertrophy in hypertensive patients.

Authors:  Ahmad I M Al-Shafei; Ola A A El-Gendy
Journal:  Physiol Rep       Date:  2019-03

4.  Incidence and impact of ischemic and hemorrhagic stroke after left ventricular assist device implantation: A nationwide study.

Authors:  Samarthkumar Thakkar; Chintan Rupareliya; Rajkumar Doshi
Journal:  Indian Heart J       Date:  2019-09-13

5.  Mesangioproliferative glomerulonephritis with extracapillary crescents - unexpected fatal complication in a 17-year-old patient with implanted left ventricular assist device.

Authors:  Elena Carmen Opriş; Horaţiu Suciu; Ioan Jung; Cătălin Bogdan Satală; Hussam Al Hussein; Marius Mihai Harpa; Cosmin Marian Bănceu; Simona Gurzu
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

6.  Heart Failure Association of the European Society of Cardiology position paper on the management of left ventricular assist device-supported patients for the non-left ventricular assist device specialist healthcare provider: Part 2: at the emergency department.

Authors:  Davor Milicic; Binyamin Ben Avraham; Ovidiu Chioncel; Yaron D Barac; Eva Goncalvesova; Avishai Grupper; Johann Altenberger; Maria Frigeiro; Arsen Ristic; Nicolaas De Jonge; Steven Tsui; Jacob Lavee; Giuseppe Rosano; Marisa Generosa Crespo-Leiro; Andrew J S Coats; Petar Seferovic; Frank Ruschitzka; Marco Metra; Stefan Anker; Gerasimos Filippatos; Stamatis Adamopoulos; Miriam Abuhazira; Jeremy Elliston; Israel Gotsman; Righab Hamdan; Yoav Hammer; Tal Hasin; Lorrena Hill; Osnat Itzhaki Ben Zadok; Wilfried Mullens; Sanemn Nalbantgil; Massimo Francesco Piepoli; Piotr Ponikowski; Luciano Potena; Arjang Ruhparwar; Aviv Shaul; Laurens F Tops; Stephan Winnik; Tiny Jaarsma; Finn Gustafsson; Tuvia Ben Gal
Journal:  ESC Heart Fail       Date:  2021-09-14

7.  The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices.

Authors:  Bianca Auschra; Markus J Wilhelm; Claudia Husung; Josef Jenewein; Andreas J Flammer; Lena Jellestad
Journal:  BMC Cardiovasc Disord       Date:  2022-03-22       Impact factor: 2.298
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.